Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Download in electronic PDF format for $75
Abstract: Medical treatment of eye disease in animals can be challenging, as the clinician must consider not only the pharmacological principles of the drug being administered but also the species being treated, the behavior of the animal and the ocular disease process itself. In addition, practical and economic considerations often dictate whether the animal will receive the optimal therapy and dosing regimen. The purpose of this article is to provide the compounding pharmacist with an overview of basic anatomy and physiology of the eye, pharmacologic principles of veterinary ophthalmics and special therapeutic considerations and to discuss selected ocular diseases that commonly affect dogs, cats and horses.
Related Keywords:
Davidson, Gigi S., BS, RPh, FSVHP, DICVP, Ocular disease, feline, treatment of, Pharmacology, for feline ocular disease
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1
Davidson Gigi S
|
May/Jun 2004
Pg. 169-172
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
|
Jul/Aug 2004
Pg. 277-283
|
Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
|
Jul/Aug 2003
Pg. 288-291
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3
Davidson Gigi S
|
Sep/Oct 2004
Pg. 359-367
|
The Treatment of Canine Atopic Disease
Davidson Gigi S
|
May/Jun 2002
Pg. 210-215
|
Treating Canine Hepatic Disease
Davidson Gigi S
|
May/Jun 2003
Pg. 188-191
|
Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
|
Mar/Apr 2001
Pg. 92-94
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Compounding for Feline Herpetic Keratitis
Davidson Gigi S
|
Nov/Dec 2006
Pg. 411-414
|
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
|
May/Jun 2002
Pg. 171-176
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
|
May/Jun 2012
Pg. 190-195
|
Sensitization Therapy for Warts
Kuntz Rachael
|
Jul/Aug 2003
Pg. 266-270
|
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 108-111
|
Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson Gigi S
|
Sep/Oct 2002
Pg. 332-336
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy, Williams LaVonn
|
Jul/Aug 2022
Pg. 293-296
|
Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Vail Jane
|
Jan/Feb 2002
Pg. 16-18
|
Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L, Muller George
|
Sep/Oct 2010
Pg. 382-394
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
| Return to Top |
